DENVER, Oct. 31, 2017 /PRNewswire/ -- DaVita Kidney
Care, a division of DaVita Inc. (NYSE: DVA), a leading provider of
kidney care services in the United
States, today announced results of the first performance
year in the Centers for Medicare and Medicaid Services (CMS)
Comprehensive ESRD Care (CEC) Model as an ESRD Seamless Care
Organization (ESCO).
CMS recognizes that end stage renal disease (ESRD) patients
benefit greatly from integrated care. The CEC model enables
dialysis providers like DaVita to partner with nephrologists to
improve clinical outcomes through holistic care coordination.
Overall, ESCOs achieved savings of $75
million during the first performance year of the pilot
program, suggesting that the renal community is uniquely poised to
deliver success on a large scale, which would positively benefit
patients, the health care system and participating providers.
"DaVita is committed to partnering with CMS on the long-term
vision of providing the gift of integrated care to all ESRD
patients," said Javier Rodriguez,
president and CEO of DaVita Kidney
Care. "We're proud to be part of a disease-specific pilot
that has shown great results for patients, is a win for the health
care system and demonstrates that the renal community is ready to
provide integrated care to all patients."
DaVita and its partners currently participate in three ESCOs
located in Arizona, Florida and New
Jersey/Pennsylvania.
DaVita's ESCO model of care leverages the 12-15 hours per week when
patients are in a dialysis clinic to address their kidney and
non-kidney health care needs. DaVita's in-person, direct patient
engagement model of care is designed to yield the best quality and
clinical outcomes over the long term.
"DaVita's integrated care team regularly communicates with
nephrologists to better address gaps in care that extend beyond
dialysis," added Dr. Roy Marcus,
medical director and participating ESCO nephrologist. "This
frequent communication means I have the time and details I need to
provide better, more holistic care to my patients."
All of DaVita's ESCOs achieved the triple aim of improving
clinical outcomes, enhancing patient experience and reducing costs.
In the first performance year, DaVita's ESCOs provided integrated
care and improved clinical outcomes for more than 5,000 patients*.
This resulted in total average savings of $4,868 per patient. In the fourth quarter of
2016, when compared to the same timeframe in 2015, hospital
readmissions were reduced by 13 percent, based on DaVita's internal
data analysis. This resulted in patients being able to spend over
2,700 more days at home due to avoided hospitalizations, including
Long-Term Acute Care Hospitals (LTACH) and Skilled Nursing
Facilities (SNF).
"DaVita and our nephrologist partners are investing resources in
an in-person model of care because it leverages the time patients
already have with their trusted care team at the dialysis center.
This approach enables timely and effective management of patients'
kidney disease, primary care and other comorbid conditions," stated
Dr. Bryan Becker, MD, MMM, FACP,
CPE, chief medical officer of DaVita VillageHealth. "DaVita is
prepared to expand its integrated care model to dialysis patients
across the country so they can experience the benefits."
The ESCO pilot is an important step in the evolution to full
risk models, but requires important modifications to enable
scalability over an extended period of time. DaVita and its
partners will continue to work with Center for Medicare &
Medicaid Innovation (CMMI), CMS and Congress to create a model that
could provide integrated care to all ESRD Medicare patients.
*Patients refers to number of beneficiary years. See CEC
Model Performance Year 1 Results.
About DaVita VillageHealth
As the country's largest
NCQA-accredited renal provider, VillageHealth® is the integrated
care division of DaVita Kidney Care.
VillageHealth's 600 teammates serve more than 20,000 end-stage
renal disease (ESRD) and late-stage chronic kidney disease (CKD)
patients each month. By partnering with health plans, the
government, health systems and nephrologists, VillageHealth
measurably improves clinical outcomes, enhances patient experience,
and reduces total cost of care for renal populations participating
in its integrated care programs. VillageHealth's partnership models
include traditional fee-for-service, shared savings, and
fully-delegated risk arrangements. VillageHealth has been fully
capitated in the industry's longest-running Medicare Advantage ESRD
Chronic Condition Special Needs Plan (C-SNP) since 2011 and now
operates twelve ESRD C-SNPs, three ESRD Seamless Care Organizations
(ESCOs), as well as more than a dozen programs with commercial
payors and health systems. For more information, please visit
VillageHealth.com.
About DaVita Kidney
Care
DaVita Kidney
Care is a division of DaVita Inc., a Fortune 500® company,
that through its operating divisions provides a variety of health
care services to patient populations throughout the United States and abroad. A leading
provider of dialysis services in the
United States, DaVita Kidney
Care treats patients with chronic kidney failure and end
stage renal disease. DaVita Kidney
Care strives to improve patients' quality of life by
innovating clinical care, and by offering integrated treatment
plans, personalized care teams, and convenient health-management
services. As of June 30, 2017,
DaVita Kidney Care operated or
provided administrative services at 2,445 outpatient dialysis
centers located in the United
States serving approximately 194,600 patients. The company
also operated 217 outpatient dialysis centers located in 11
countries outside the United
States. DaVita Kidney Care
supports numerous programs dedicated to creating positive,
sustainable change in communities around the world. The company's
leadership development initiatives and social responsibility
efforts have been recognized by Fortune, Modern Healthcare,
Newsweek, and WorldBlu. For more information, please visit
DaVita.com.
Forward Looking Statements
This release contains or
may contain statements that are forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21E of the Securities Exchange Act of 1934, as
amended. We intend these forward-looking statements to be covered
by the safe harbor provisions for such statements. All statements
that do not concern historical facts are forward-looking statements
and include, among other things, statements about our expectations,
beliefs, intentions and/or strategies for the future. These
forward-looking statements include statements regarding anticipated
benefits of integrated care to patient, tax payers and
participating providers, scalability of ESCOs, improvement in
clinical outcomes, enhancement in patient experience, reduction in
costs, and ability to yield the best quality and clinical outcomes
over the long term. These statements can sometimes be identified by
the use of forward looking words such as "may," "believe," "will,"
"should," "could," "would," "expect," "project," "estimate,"
"anticipate," "plan," "continue," "seek," "forecast," or "intend"
or other similar words or expressions of the negative thereof.
These statements involve substantial known and unknown risks and
uncertainties that could cause our actual results to differ
materially from those described in the forward-looking statements,
including, but not limited to the risk factors set forth in the
Company's Annual Report on Form 10-K for the year ended
December 31, 2016, and subsequent
quarterly reports on Form 10-Q. These forward-looking statements
should be considered in light of these risks and uncertainties. All
forward-looking statements in this release are based on information
available to us on the date of this release. We undertake no
obligation to publicly update or revise any of these
forward-looking statements, whether as a result of changed
circumstances, new information, future events or otherwise.
Disclaimer
The statements contained in this
document are solely those of the authors and do not necessarily
reflect the views or policies of CMS. The authors assume
responsibility for the accuracy and completeness of the information
contained in this document
Media contact:
Kate
Stabrawa
(303) 876-7527
Kate.Stabrawa@davita.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/integrated-care-improves-dialysis-patient-clinical-outcomes-300546805.html
SOURCE DaVita Kidney Care